risperidone has been researched along with Bone Fractures in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Risperidone and aripiprazole, commonly used antipsychotics in children with autism spectrum disorder (ASD), have previously been associated with elevated fracture risk in other populations." | 8.02 | Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders. ( de Vries, F; Houghton, R; Law, K; Liu, Y; van den Bergh, J, 2021) |
| "Risperidone and aripiprazole, commonly used antipsychotics in children with autism spectrum disorder (ASD), have previously been associated with elevated fracture risk in other populations." | 4.02 | Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders. ( de Vries, F; Houghton, R; Law, K; Liu, Y; van den Bergh, J, 2021) |
| "The aim of the present study was to investigate the effect of risperidone-induced hyperprolactinemia on trabecular bone mineral density (BMD) in children and adolescents." | 3.76 | A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. ( Calarge, CA; Kuperman, S; Schlechte, JA; Xie, D; Zimmerman, B, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houghton, R | 1 |
| van den Bergh, J | 1 |
| Law, K | 1 |
| Liu, Y | 1 |
| de Vries, F | 1 |
| Fraser, LA | 1 |
| Liu, K | 1 |
| Naylor, KL | 1 |
| Hwang, YJ | 1 |
| Dixon, SN | 1 |
| Shariff, SZ | 1 |
| Garg, AX | 1 |
| Calarge, CA | 1 |
| Zimmerman, B | 1 |
| Xie, D | 1 |
| Kuperman, S | 1 |
| Schlechte, JA | 1 |
| Chatterjee, S | 1 |
| Chen, H | 1 |
| Johnson, ML | 1 |
| Aparasu, RR | 1 |
4 other studies available for risperidone and Bone Fractures
| Article | Year |
|---|---|
Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Child; Cohort Studies; Fem | 2021 |
Falls and fractures with atypical antipsychotic medication use: a population-based cohort study.
Topics: Accidental Falls; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzot | 2015 |
A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
Topics: Absorptiometry, Photon; Adolescent; Anthropometry; Antipsychotic Agents; Body Mass Index; Bone Densi | 2010 |
Risk of falls and fractures in older adults using atypical antipsychotic agents: a propensity score-adjusted, retrospective cohort study.
Topics: Accidental Falls; Aged; Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; F | 2012 |